Cell Therapy Catapult appoints Eversheds as legal adviser
Eversheds has been appointed as legal adviser to the Cell Therapy Catapult, a UK centre of excellence in cell therapy, following a competitive pitch process.
The law firm’s appointment will cover all aspects of the Cell Therapy Catapult’s operations, including intellectual property and life sciences issues, procurement and state aid, HR, real estate and construction.
The Cell Therapy Catapult was established by the UK government’s Technology Strategy Board in 2012 to grow the UK cell therapy industry by removing the barriers to translation of promising therapies and technologies into new products.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
European Commission proposes reforms to merger control regime; how will this affect the aviation sector?
The European Commission has produced a white paper setting out proposals to improve and extend European Union merger control.
The potential impact of Ebola is of interest to all corporations with a presence in Africa, and in particular to those with projects, assets and personnel in the countries affected.
Analysis from The Lawyer
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe